ストックスクリーナーアプリを入手
26.99
3.16%
-0.88
アフターアワーズ：
27.70
0.71
+2.63%
前日終値:
$27.87
開ける：
$27.75
24時間の取引高:
610.80K
Relative Volume:
0.35
時価総額：
$1.70B
収益：
$18.09M
当期純損益:
$-208.87M
株価収益率:
-7.684
EPS:
-3.5125
ネットキャッシュフロー:
$-178.15M
1週間 パフォーマンス:
+2.00%
1か月 パフォーマンス:
-0.22%
6か月 パフォーマンス:
+23.30%
1年 パフォーマンス:
+78.62%
1日の値動き範囲:
$26.65
$27.90
1週間の範囲:
$25.97
$28.71
52週間の値動き範囲:
$8.73
$71.50
Uniqure Nv Stock (QURE) Company Profile
Compare QURE vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure Nv
|
26.99 | 1.76B | 18.09M | -208.87M | -178.15M | -3.5125 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Uniqure Nv Stock (QURE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-11 | アップグレード | Mizuho | Neutral → Outperform |
| 2026-03-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2026-03-09 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-03-03 | ダウングレード | Mizuho | Outperform → Neutral |
| 2026-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2026-03-02 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2026-03-02 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-24 | 開始されました | Wolfe Research | Peer Perform |
| 2026-01-28 | 開始されました | Barclays | Equal Weight |
| 2025-11-04 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | アップグレード | Mizuho | Neutral → Outperform |
| 2025-04-01 | 再開されました | Chardan Capital Markets | Buy |
| 2024-12-10 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-02-29 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-03-17 | アップグレード | UBS | Neutral → Buy |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-21 | 開始されました | UBS | Neutral |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-04-01 | アップグレード | Mizuho | Neutral → Buy |
| 2021-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-24 | 開始されました | H.C. Wainwright | Buy |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-11-09 | 開始されました | Jefferies | Buy |
| 2020-11-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-08-25 | 開始されました | Raymond James | Strong Buy |
| 2020-07-31 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | ダウングレード | Mizuho | Buy → Neutral |
| 2020-06-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | 開始されました | Cowen | Outperform |
| 2019-12-03 | 開始されました | Goldman | Buy |
| 2019-11-05 | 開始されました | Credit Suisse | Outperform |
| 2019-10-11 | 開始されました | Stifel | Buy |
| 2019-09-25 | 開始されました | Bernstein | Outperform |
| 2019-09-12 | 開始されました | Mizuho | Buy |
| 2019-07-30 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-07-08 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2019-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2019-03-29 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Uniqure Nv (QURE) 最新ニュース
uniQure (QURE) investors approve share plan, charter and board at 2026 AGM - Stock Titan
[144] uniQure N.V. SEC Filing - Stock Titan
Don't Ignore The Insider Selling In uniQure - simplywall.st
This Insider Has Just Sold Shares In UniQure - Moomoo
QURE Stock Just Shot Up 8%uniQure’s Much-Talked-About Huntington’s Disease Therapy Gets A UK Boost - Stocktwits
Why Did QURE Stock Almost Halve Pre-Market Today? - Stocktwits
RSU grant, options and tax sale for uniQure (NASDAQ: QURE) director - Stock Titan
uniQure (QURE) director trades shares, receives RSUs and stock options - Stock Titan
Tax-related share sale by uniQure (NASDAQ: QURE) chief customer officer - Stock Titan
uniQure (QURE) director receives RSUs, stock options and sells shares for taxes - Stock Titan
uniQure (QURE) director Leonard Post awarded RSUs, options and sells shares for taxes - Stock Titan
Director Jack Kaye at uniQure (QURE) gets RSUs and options, sells shares for taxes - Stock Titan
Equity awards and tax-driven share sale for uniQure (NASDAQ: QURE) director - Stock Titan
uniQure (NASDAQ: QURE) director awarded RSUs, sells shares for taxes - Stock Titan
What Caused uniQure's Dramatic Stock Plunge - Kavout
symbol__ Stock Quote Price and Forecast - CNN
UniQure (NASDAQ: QURE) reports 7,970 RSUs vest and 10,000-share 10b5-1 sale - Stock Titan
UniQure N.V. (QURE) files Rule 144 to sell 7,970 RSU shares on 06/11/2026 - Stock Titan
Jack Kaye sale notice at UniQure (NASDAQ: QURE) — 7,970 shares proposed - Stock Titan
QURE Shareholder Alert: Investors With Losses May Seek to Lead t - GuruFocus
Trading the Move, Not the Narrative: (QURE) Edition - Stock Traders Daily
Fiera Capital Corp Invests $18.39 Million in uniQure N.V. $QURE - MarketBeat
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 - Stocktwits
What Just Happened with uniQure's Earnings and FDA Update - Kavout
QURE Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesWeak Earnings Momentum - newsline.com
Director Kaye trades uniQure (QURE) shares in 10b5-1 option exercise and sale - Stock Titan
Huntingtons Disease Market Size to Hit USD 6.48 Billion by 2035 - Precedence Research
Mizuho downgrades UniQure NV (QURE) - MSN
Form 144 uniQure N.V. For: 3 June By Investing.com - Investing.com South Africa
uniQure: Why A Shifting FDA Could Change Everything For AMT-130 (NASDAQ:QURE) - Seeking Alpha
Tracing UniQure's Tale Of Boom, Bust, And Rebound - RTTNews
(QURE) Volatility Zones as Tactical Triggers - Stock Traders Daily
uniQure stock surges 20% on Replimune FDA BLA news By Investing.com - Investing.com Australia
uniQure stock surges 20% on Replimune FDA BLA news - Investing.com
QURE News | UNIQURE NV (NASDAQ:QURE) - ChartMill
uniQure N.V. stock (IL0011559904): Gene therapy player navigates strategic reset and cash conservati - AD HOC NEWS
uniQure Q1 2026 Earnings: Narrower-Than-Expected Loss Amid No Revenue, Stock SlipsCapex Guidance - newsline.com
Numero AI and Royu Merge to Redefine How Finance Teams Operate - Benzinga
UniQure stock falls after FDA's notes on pre-application of AMT-130 - MSN
Considering Uniqure NV (QURE) Stock? Read the AMT-130 Message - Insider Monkey
Uniqure NV at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
uniQure N.V. (QURE) Stalls at $24.84 — Breakout or Breakdown? 2026-05-19PCR Moving Average - newsline.com
Price-Driven Insight from (QURE) for Rule-Based Strategy - Stock Traders Daily
Huntington's Disease Pipeline 2026: Therapies Under - openPR.com
UniQure NV (QURE) price target decreased by 26.57% to 37.82 - MSN
Mizuho maintains uniQure NV (QURE) outperform recommendation - MSN
QURE stock just shot up 8%uniQure’s much-talked-about Huntington’s disease therapy gets a UK boost - MSN
Uniqure Nv (QURE) 財務データ
収益
当期純利益
現金流量
EPS
Uniqure Nv (QURE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Meek David D. | Director |
Jun 11 '26 |
Sale |
27.06 |
1,993 |
53,931 |
39,747 |
| Gut Robert | Director |
Jun 10 '26 |
Option Exercise |
16.04 |
2,645 |
42,426 |
34,987 |
| Gut Robert | Director |
Jun 10 '26 |
Sale |
26.05 |
7,552 |
196,720 |
27,435 |
| Gut Robert | Director |
Jun 11 '26 |
Sale |
27.06 |
2,726 |
73,766 |
32,259 |
| O'Keefe Kylie | Chief Customer & Strat Officer |
Jun 11 '26 |
Sale |
27.06 |
15,936 |
431,228 |
108,864 |
| Springhorn Jeremy P. | Director |
Jun 11 '26 |
Sale |
27.06 |
1,993 |
53,931 |
43,251 |
| POST LEONARD E | Director |
Jun 11 '26 |
Sale |
27.06 |
1,993 |
53,931 |
35,494 |
| Kaye Jack | Director |
Jun 11 '26 |
Sale |
27.06 |
1,993 |
53,931 |
25,996 |
| Jacques Rachelle Suzanne | Director |
Jun 11 '26 |
Sale |
27.06 |
1,993 |
53,931 |
33,903 |
| Balachandran Madhavan | Director |
Jun 11 '26 |
Sale |
27.06 |
1,993 |
53,931 |
43,254 |
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):